Items where authors include "Schnitzer, TJ"

Article

Conaghan, PG orcid.org/0000-0002-3478-5665, Dworkin, RH, Schnitzer, TJ et al. (5 more authors) (2022) WOMAC Meaningful Within-patient Change: Results From 3 Studies of Tanezumab in Patients With Moderate-to-severe Osteoarthritis of the Hip or Knee. The Journal of Rheumatology. ISSN 0315-162X

Schnitzer, TJ, Berenbaum, F, Conaghan, PG orcid.org/0000-0002-3478-5665 et al. (7 more authors) (2021) Single and Composite Endpoints of Within-Patient Improvement in Symptoms: Pooled Tanezumab Data in Patients With Osteoarthritis. Rheumatology and Therapy, 8. pp. 1759-1774. ISSN 2198-6584

Smith, TO, Hawker, GA, Hunter, DJ et al. (25 more authors) (2019) The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee Osteoarthritis. Journal of Rheumatology, 46 (8). jrheum.181194. pp. 981-989. ISSN 0315-162X

Smith, TO, Mansfield, M, Hawker, GA et al. (25 more authors) (2019) Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017. Journal of Rheumatology, 46 (8). pp. 976-980. ISSN 0315-162X

Fleischmann, RM, Bliddal, H, Blanco, FJ et al. (17 more authors) (2019) A Phase II Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis. Arthritis & Rheumatology, 71 (7). pp. 1056-1069. ISSN 2326-5191